Ambrx Biopharma Inc.

28.00
0.02 (0.07%)
At close: Mar 06, 2024, 9:00 PM

Ambrx Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
-67.06M -59.63M -70.65M -78M -67.06M -51.49M -22.65M
1.49M 1.43M 1.61M 1.8M 1.43M 1.1M 558K
10.83M 7.55M 6.54M 6.25M 5.07M 3.53M 1.65M
-6.1M -5.53M -4.57M -7.2M -5.66M -4.7M -7.22M
2.43M 2.67M 9.61M 12.34M 11.66M 10.73M 3.15M
278K -481K -453K -453K -233K n/a n/a
-5.67M -6.14M -2.63M -10.62M -6.84M -4.07M -8.37M
-57.7M -54.6M -55.98M -68.67M -55.97M -40.2M -25.66M
-1.13M -934K -280K -1.05M -1.01M -903K -774K
-8.82M -20.8M -20.8M -20.8M -11.98M n/a n/a
-50.07M -62.2M -125.5M -84.85M -75.43M -63.3M n/a
113.83M 119.35M 109.39M 39.19M 11.98M n/a n/a
8.82M 20.8M 20.8M 20.8M 11.98M n/a n/a
62.64M 56.22M -16.39M -46.72M -64.46M -64.2M -774K
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a
170.06M 160.83M 78.16M 928K 447K -34K -6K
170.06M 160.83M 78.16M 928K 447K -34K -6K
174.01M 162.46M 5.79M -114.47M -118.99M -104.43M -26.44M
-58.83M -55.53M -56.26M -69.73M -56.98M -41.1M -26.44M